Scientific article

Résistances thérapeutiques dans les mouvements anormaux

Published inRevue médicale suisse, vol. 8, no. 339, p. 926-929
Publication date2012

Therapeutic strategies for essential tremor (ET) and Parkinson's disease (PD) can be divided into two successive steps, one based on oral medications and the other, more invasive, using pumps or functional neurosurgery. When ET becomes refractory to propranolol, primidone and other, second-choice compounds, deep brain stimulation of the VIM nucleus of the thalamus can be considered. When PD becomes resistant to dopamine replacement therapy using various combinations of dopaminergic agents, then three options can be discussed: first, a subcutaneous apomorphine mini-pump, second, a jejunal levodopa-delivery system by means of percutaneous gastrostomy, and third, bilateral deep brain stimulation of the subthalamic nucleus. The above interventions are successful in about 80% of cases.

  • Antiparkinson Agents/administration & dosage/therapeutic use
  • Apomorphine/administration & dosage/therapeutic use
  • Deep Brain Stimulation/methods/psychology/utilization
  • Drug Resistance/physiology
  • Essential Tremor/diagnosis/etiology/therapy
  • Humans
  • Levodopa/administration & dosage/therapeutic use
  • Movement Disorders/diagnosis/etiology/therapy
  • Neurosurgery/methods
  • Parkinson Disease/diagnosis/etiology/therapy
  • Treatment Failure
Citation (ISO format)
VINGERHOETS, François, BURKHARD, Pierre. Résistances thérapeutiques dans les mouvements anormaux. In: Revue médicale suisse, 2012, vol. 8, n° 339, p. 926–929.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation01/02/2014 4:57:00 PM
First validation01/02/2014 4:57:00 PM
Update time03/14/2023 8:48:10 PM
Status update03/14/2023 8:48:10 PM
Last indexation05/02/2024 1:40:09 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack